Skip to main content
Equibles
BTCY logo

BTCY · Biotricity Inc.

Track BTCY — free

Use BTCY with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about BTCY

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.12 0.00 (-1.69%) At close · Aug 14
Going-concern doubt — flagged Jul 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Management has previously noted the existence of substantial doubt about our ability to continue as a going concern. Additionally, our independent registered public accounting firm included an explanatory paragraph in the report on our financial statements as of and for the years ended March 31, 2026 and 2025, respectively, noting the existence of substantial doubt about our ability to continue as a going concern.”
View the 10-K filed Jul 14, 2026
Market Cap
$2.33M
Shares
20.07M

Biotricity Inc. Earnings Call Transcripts

Every quarterly earnings call for Biotricity Inc. (BTCY) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲115.3% $744,585 −$2.96M '21 Q2 20-11-20 ▲162.2% $1.00M −$3.90M '21 Q3 21-02-12 ▲227.1% $1.19M −$5.47M '21 Q4 21-06-17 ▲290.4% $1.76M −$5.66M '22 Q1 21-08-17 ▲92.8% $1.93M −$7.11M '22 Q3 22-02-16 ▲81% $2.15M −$5.61M '22 Q4 22-03-31 ▲16.5% $2.06M −$4.78M '23 Q1 22-08-17 ▲31.8% $2.38M −$4.69M '23 Q2 22-11-18 ▲27.4% $2.46M −$4.52M '23 Q3 22-12-31 ▲46.9% $3.02M −$3.41M '24 Q1 23-07-05 ▲20.9% $2.97M −$2.81M '24 Q3 23-12-31 ▲13% $3.27M −$1.56M '25 Q2 24-11-20 ▲21.7% $3.62M −$1.23M '25 Q3 25-02-24 ▲16.5% $3.70M −$1.94M '25 Q4 25-03-31 ▲18.9% $3.89M −$690,913 '26 Q2 25-11-18 LATEST ▲10.2% $3.99M −$717,067 '26 Q3 26-02-18
Earnings call
FY26 · Q3
2026-02-18
Biotricity Inc. Q3 FY2026 Earnings Call
Revenue
$3.99M
▲ 10.2% YoY
Diluted EPS
$-0.04
Gross margin
81.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2025-11-18
Biotricity Inc. Q2 FY2026 Earnings Call
Revenue
$3.89M
▲ 18.9% YoY
Diluted EPS
$-0.03
Gross margin
81.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-03-31
Biotricity Inc. Q4 FY2025 Earnings Call
Confident tone Biocore Pro flagship device adoption Revenue growth and gross margin expansion Cardiac AI cloud platform and FDA clearance
Revenue
$3.70M*
▲ 16.5% YoY
Gross margin
80.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-02-24
Biotricity Inc. Q3 FY2025 Earnings Call
Revenue
$3.62M
▲ 21.7% YoY
Diluted EPS
$-0.05
Gross margin
76.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2024-11-20
Biotricity Inc. Q2 FY2025 Earnings Call
Revenue
$3.27M
▲ 13% YoY
Diluted EPS
$-0.07
Gross margin
75.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q3
2023-12-31
Biotricity Inc. Q3 FY2024 Earnings Call
Revenue
$2.97M
▲ 20.9% YoY
Diluted EPS
$-0.34
Gross margin
72.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2023-07-05
Biotricity Inc. Q1 FY2024 Earnings Call
Revenue
$3.02M
▲ 46.9% YoY
Diluted EPS
$-0.41
Gross margin
63.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q3
2022-12-31
Biotricity Inc. Q3 FY2023 Earnings Call
Revenue
$2.46M
▲ 27.4% YoY
Diluted EPS
$-0.55
Gross margin
57.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2022-11-18
Biotricity Inc. Q2 FY2023 Earnings Call
Revenue
$2.38M
▲ 31.8% YoY
Diluted EPS
$-0.57
Gross margin
53.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2022-08-17
Biotricity Inc. Q1 FY2023 Earnings Call
Revenue
$2.06M
▲ 16.5% YoY
Diluted EPS
$-0.10
Gross margin
59.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-03-31
Biotricity Inc. Q4 FY2022 Earnings Call
Revenue
$2.15M*
▲ 81% YoY
Gross margin
67.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-02-16
Biotricity Inc. Q3 FY2022 Earnings Call
Revenue
$1.93M
▲ 92.8% YoY
Gross margin
42.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2021-08-17
Biotricity Inc. Q1 FY2022 Earnings Call
Revenue
$1.76M
▲ 290.4% YoY
Gross margin
66.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-06-17
Biotricity Inc. Q4 FY2021 Earnings Call
Revenue
$1.19M*
▲ 227.1% YoY
Gross margin
62.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-02-12
Biotricity Inc. Q3 FY2021 Earnings Call
Revenue
$1.00M
▲ 162.2% YoY
Gross margin
14.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2020-11-20
Biotricity Inc. Q2 FY2021 Earnings Call
Revenue
$744,585
▲ 115.3% YoY
Gross margin
18.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–16 of 16 earnings calls
Key facts CIK 1630113 CUSIP 09074H203 13F (30d) 2 filings 2 filers Visit website

Report a Problem

Category
Description
Email (optional, for follow-up)